HBOT: How Hyperbaric Oxygen Therapy Is Changing Modern Medicine

Hyperbaric Oxygen Therapy (HBOT) involves breathing pure oxygen at pressures greater than atmospheric — typically 1.5 to 3 atmospheres — inside a sealed pressurised chamber. Under these conditions, oxygen dissolves directly into blood plasma, lymph fluid, and cerebrospinal fluid at concentrations 10 to 15 times higher than normal. This oxygen supersaturation triggers a cascade of physiological responses that have made HBOT one of the most versatile tools in modern regenerative medicine.

The FDA currently approves HBOT for 14 conditions, including diabetic foot ulcers, decompression sickness, carbon monoxide poisoning, radiation tissue damage, and necrotising soft tissue infections. Beyond these approved uses, a growing body of evidence supports its application in traumatic brain injury (TBI), long COVID neurological symptoms, autism spectrum disorder, sports performance recovery, and post-surgical healing acceleration.

The TBI application has attracted particular scientific attention. Research published in multiple peer-reviewed journals demonstrates that HBOT stimulates neurogenesis — the growth of new neural tissue — and reduces neuroinflammation in patients with chronic TBI symptoms, including those from blast injuries, concussions, and stroke. Patients who had plateaued in conventional rehabilitation report measurable improvements in cognitive function, memory, and emotional regulation after 40–60 HBOT sessions.

For sports recovery, professional athletes across football, tennis, and martial arts now use HBOT as a standard part of their recovery protocols. The therapy accelerates the repair of micro-tears in muscle tissue, reduces inflammation-driven downtime, and has been shown to shorten recovery from soft tissue injuries by 30–40 percent.

A typical HBOT session runs 60 to 90 minutes. The patient enters a monoplace (single-person acrylic tube) or multiplace (multi-patient hard-shell) chamber. Pressure is gradually increased — the sensation is similar to descending in an airplane — then maintained at the therapeutic level for 60 minutes before gradual depressurisation. Most protocols involve 20–40 sessions over 4–8 weeks.

Costs range from $150 per session in India and Thailand to $250–$400 in Turkey and the UAE, to $400–$800 in the United States and Germany. Curevo's HBOT network covers 60+ verified providers globally. Our clinical team can help you determine whether the indication you're treating falls within the evidence-supported range and connect you with the appropriate provider.